Pharmacy Association of Saskatchewan

COVID-19 Resources

In response to the current public health crisis, COVID-19, PAS has created this website to collate resources and updates from PAS, the provincial, national, and international levels.

Newest Updates - October 21, 2020

PAS Support Tool - Summary of Updates, Changes, and Supports to Pharmacy Practice - August 14 (login to your PAS to access).

CPhA - Upcoming Webinar: Pharmacists as Opioid Stewards: A Showcase of the Evidence - October 28, 1-3 pm EDT

PAS Updates

Message from the PAS CEO to all Members - Email - April 21

Message from the PAS CEO to all Members - Video - April 21

Joint Statement on Use of Hydroxychloroquine (Plaquenil®) and Azithromycin for COVID-19 - March 25

March 23, 2020 Email

March 18, 2020 Email

March 13, 2020 Email

Provincial Resources

The provincial government has created guidance tools and a web page with provincial updates on the situation in Saskatchewan.

Pharmacy Policies and Legislation Updates

Saskatchewan Medication Assessment Program Compliance Packaging Update - Oct 9, 2020

The Drug Plan and Extended Benefits Branch (DBEPP) is continuing to extend the Exception Drug Status (EDS) for compliance packaging under the Saskatchewan Medication Assessment Program. As the EDS expires, the DPEBB auto-renewal process will renew the EDS for 6 months. For example, if the EDS expired in October 2020, you may have noticed it has been extended until March 2021. EDS expiring in November 2020 will be extended until April 2021. This process of extending the EDS as it expires will continue over the next couple of months and will be reviewed before the end of the year. Further updates will be provided at that time.

As there is an increased risk of more severe outcomes for COVID-19 for individuals 65 years of age and over, the DPEBB is recommending that pharmacists delay all non-urgent professional services (e.g. medication assessments) until the risk has been reduced.

If medication assessment cannot be delayed, (i.e., a new admission to a personal care home or a group home) a medication assessment may be done virtually or over the phone.

Saskatchewan Formulary Bulletins

#187 Saskatchewan Formulary Bulletin - Interim Measures Related to Exception Drug Status (EDS) Coverage During COVID-19 Pandemic – Automatic Extension of EDS Coverage - April 9

#186 Saskatchewan Formulary Bulletin - Interim Measures Related to Exception Drug Status (EDS) During COVID-19 Pandemic – Updated Listing of DOACs - April 9

#185 Saskatchewan Formulary Bulletin - Exception Drug Status (EDS) During COVID-19 Pandemic - March 24

Pharmacy Information Bulletins

#736 Pharmacy Information Bulletin - Salbutamol Metered Dose Inhaler (MDI) Shortage Update - June 8

#734 Pharmacy Information Bulletin - Province Lifts Restrictions on Prescription Filling - May 19

#730 Pharmacy Information Bulletin - Community Compliance Packaging Exception - April 21

#729 Pharmacy Information Bulletin - Virtual Visits Using Pexip - April 21

#728 Pharmacy Information Bulletin - Prescription Quantity Restrictions Updated list of exceptions - April 14

#726 Pharmacy Information Bulletin - Frequently Asked Questions Prescription Quantities - COVID-19 - April 2

#724 Pharmacy Information Bulletin- SMAPs During COVID-19 - March 20

#723 Pharmacy Information Bulletin - Reduced Telephone Coverage - March 20

Letter from the Deputy Minister of Health - Letter on the prescription quantities - March 18

Prescription Quantities Restrictions Effective Immediately - Prescription quantities from the DPEBB - March 18

Saskatchewan Government Resources

Re-Open Saskatchewan - June 8 Target Date for Phase 3 - May 21

Public Health Orders - May 20

Province Lifts Limits on Filling Prescriptions - May 19

Cases and Risk of COVID-19 in Saskatchewan - Provincial map showing cases in the province

Self-Assessment Tool - COVID-19 Online Assessment

Saskatchewan COVID-19 Preparedness Plan - Provincial Plan

Mass Gatherings, Risk for Elderly Population - Guidance Resource

Self-Monitoring Information Sheet - Guidance Resource

Self-Isolation Information Sheet - Guidance Resource

COVID-19 FAQ

Public Health Orders - March 26

Website - Saskatchewan Government COVID-19 site

Saskatchewan Health Authority

New Pandemic Modelling Shows Improved Outlook for Saskatchewan - April 28

Expanding Capacity for COVID-19- March 25

Saskatchewan Health Authority Resources Website

Saskatchewan College of Pharmacy Professionals

Emergency Licenses No Longer Required - June 29

Supporting Saskatchewan Regulated Health Care Professionals during the COVID-19 Response - May 12

Virtual Care - April 22

Emergency Licensure Provisions Bylaw Amendments including Amendments to Provide Interns with the Authority to Complete AMC in an Emergency - April 20

Prescriptions Direct from PIP - April 14

Prescribing, Dispensing, Continuation of Therapy During COVID-19 - April 1

Safety Measure and Changes to Chain of Signature - March 27

Exemption 56 Status Update - March 27

Exemptions to the Opioid Agonist Therapy “OAT’ Standards During the COVID-19 Pandemic - March 27

PAR and Notification to Patient’s Provider - March 27

Updated Modified Pharmacy Operations and Reducing Hours - March 27

Privacy Concerns – Reporting Patients Not Complying with the Legal Requirement to Quarantine - March 27

Saskatchewan College of Pharmacy Professionals - Web page of resources, tools and updates on COVID-19

SCPP website

RxFiles

RxFiles Website - Useful links and resources

medSask

H2- receptor antagonist shortage - May 25

Can I breastfeed my baby if I have COVID-19? - May 1

Is nicotine protective against COVID-19? - May 1

What are some resources to manage patients with asthma or COPD - April 23

Pharmacist-Administered Injections: Considerations during COVID-19 Pandemic - April 23

What precautions need to be taken when preparing compliance packaging - April 20

medSask - Fluticasone Shortage Document

medSask - Guidelines and Recommendations for appropriate cleaning and disinfection of Community Pharmacy surfaces during COVID-19

medSask - Important resources for managing drug shortages

medSask - web resource on drug shortages

medSask - resources on COVID-19

Posters, Graphics & Videos

Blue Version - PAS/SMA/SCPP/CPSS Prescription Poster

White Version - PAS/SMA/SCPP/CPSS Prescription Poster

Social Media Version - PAS/SMA/SCPP/CPSS Prescription Poster

Pharmacy Poster - Ministry of Health

Prevention Poster - Ministry of Health

Need to Visit a Pharmacy Poster - CPhA

Video on Maintain a Stable Drug Supply - CPhA

Facebook Graphic - CPhA

Twitter Graphic -CPhA

Social Media Post - CPhA

National Resources

Several national agencies and departments have created guidance tools and are providing updates on the situation in Canada.

The Controlled Substances Bulletin - Update to Requirements for Post Consumer Returns Containing Controlled Substances - September 23

National Collaborating Centre for Infectious Diseases 2020-2021 Seasonal Influenza Webinar - September 21

New List of Health Care Practitioners and Pharmacists Named in a Notice of Restriction - August 14

Essential Services Contingency Reserve for PPE Launched - July 22

Health Canada recalls some hand sanitizers over industrial grade ethanol content - June 11

Be a Good Steward of Medication - June 1

Controlled Substances Bulletin – Update to Requirements for Post-Consumer Returns Containing Controlled Substances - April 16

Guidance on Essential Services and Functions in Canada During COVID-19 - Government of Canada website

Coronavirus Disease - Government of Canada website

Vulnerable Populations - Health Canada Guidance Document

Community-Based Measures to Mitigate - Government of Canada Guidance Document

How to Isolate at Home When You have COVID-19 - Public Health Agency of Canada

The Public Health Agency of Canada - their website

Travel Advisories - Government of Canada

CPhA Statements

Pharmacists continue to have difficulty sourcing certain medications during COVID-19 pandemic - May 27

Dipryridamole/ASA Shortage - April 30

First Ministers Joint Letter - March 23, 2020 - Protecting and supporting Canada’s health-care providers during COVID-19

CPhA Statement - March 23, 2020 - Treatment of COVID-19 With Chloroquine or Hydroxychloroquine

CPhA Statement - March 23, 2020 - 30 Day Supply of Prescription Medications

Open Letter to the Government of Canada - March 18, 2020 Re: Access to Personal Protective Equipment for Pharmacy Professionals

Public Statement - March 4, 2020

Key Messages - For the Public